The gene pool identified to be regulated by BET proteins was differentially expressed in inflammatory cells from COPD patients and healthy controls, and could thus be used for the identification of the patients who benefit from BET inhibition as a therapy. Here, DNER is linked to chronic obstructive pulmonary disease.